The Japanese Journal of Pediatric Hematology / Oncology
Online ISSN : 2189-5384
Print ISSN : 2187-011X
ISSN-L : 2187-011X
Original Article
Diagnostic test for discriminating between hereditary spherocytosis and other hemolytic anemias
Atsushi Shibuya
Author information
JOURNAL FREE ACCESS

2016 Volume 53 Issue 2 Pages 97-104

Details
Abstract
Hereditary spherocytosis (HS) is a common syndrome characterized by abnormal quantities of red cell membrane proteins. In this study, we attempted to establish a simple diagnostic technique that can discriminate between HS and other conditions, such as congenital hemolytic anemia, β thalassemia (β thal), hemoglobinopathy (HP), autoimmune hemolytic anemia (AIHA), erythroenzymopathy, and iron deficiency anemia. We studied peripheral blood red cells stained with standard Wright–Giemsa and eosin-5′-maleimide (EMA), and evaluated red cell hemoglobin peak patterns by high-performance liquid chromatography (HPLC). Furthermore, the remainder of the blood sample was biochemically analyzed for quantities of red cell membrane proteins by SDS-polyacrylamide gel electrophoresis (PAGE). Red blood cells from pre-splenectomized HS (pre-HS) patients were faintly stained with EMA, whereas those from other patients and controls were brilliantly stained. Pre-HS patients exhibited lower quantities of the band 3 protein than patients with other anemias. The hemoglobin peak patterns showed abnormal and characteristic waves for patients with HP, β thal, and AIHA, but not in pre-HS or post-splenectomized HS (post-HS) patients, IDD, and controls. Pre-HS patients with low quantities of the band 3 protein showed red blood cells faintly stained with EMA, which correlated with HS and other hemolytic anemias. Red blood cells from post-HS patients were stained similarly to those from controls but were stained more brilliantly than those from pre-HS patients. Thus, these two simple techniques, EMA staining and HPLC, along with SDS-PAGE, enable the discrimination between the initial stages of HS and other anemias. However, DNA analyses may be necessary for cases where these methods cannot adequately distinguish between the conditions.
Content from these authors
© 2016 The Japanese Society of Pediatric Hematology / Oncology
Previous article Next article
feedback
Top